TailorMed Showcases Innovative Patient-Facing Solution at Becker's Fall Chief Pharmacy Officer Summit

November 5, 2025 8:00 AM

TailorMed, a leading healthcare technology company, announced it will exhibit its new patient experience solution, TailorMed Connect, at Becker's Fall Chief Pharmacy Officer Summit. The event takes place on November 5-6, 2025 at the Hilton Chicago in Chicago, IL. TailorMed will be at booth 2108 throughout the exhibition.For years, TailorMed has partnered with leading health systems to eliminate barriers that stand between patients and their...

Read more

The Psychedelic Debate: Scientists and Scholars Clash on the Future of Therapy at Cannadelic Global

November 5, 2025 7:00 AM

The future of psychedelic medicine is not quiet, and it is not unanimous. At this year's Cannadelic Global Summit, the Southeast's largest psychedelic and integrative wellness conference, some of the sharpest minds in neuroscience, clinical practice, ethics, and psychotherapeutic innovation are preparing to confront the most important question facing the field:Where is psychedelic medicine actually going - and who gets to define it?Held November...

Read more

enBio Leads the Industry with a New Standard of Fairness and Transparency in Healthcare Technology Management (HTM)

November 5, 2025 7:00 AM

As hospitals and clinics grapple with rising costs and unpredictable service pricing, enBio Corp is taking a principled stand - introducing a national model built on transparency, value, and accountability. The company has launched a consistent, coast-to-coast pricing framework designed to bring clarity and fairness back to Healthcare Technology Management (HTM) and biomedical service delivery. Grounded in three core principles - transparent...

Read more

Invitation to the Presentation of Cantargia's Interim Report January-September 2025

November 5, 2025 3:45 AM

Cantargia (STO:CANTA) - Cantargia AB (publ) (Nasdaq Stockholm:CANTA) will publish the company's interim report for the first nine months of 2025 on Wednesday, November 19, 2025, at 07:00 a.m. CET.In conjunction to the report, investors, analysts, and media are invited to an audiocast with teleconference (in English) on November 19, at 3:00 p.m. CET, where Cantargia's CEO Hilde Steineger, CMO Wolfram Dempke, and CFO Patrik Renblad, will present...

Read more

Quarterly Report Q3 2025: Orviglance NDA Submitted to the FDA

November 5, 2025 2:00 AM

Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (ticker:ACE) today published its Interim Report Q3 for 2025 (January - September), which is now available on the company's website: Financial Reports - ASCELIAKEY EVENTS IN Q3 2025New Drug Application (NDA) for Orviglance® submitted to the US Food and Drug Administration (FDA)Directed share issue of approximately SEK 30 million completedFenja Capital II A/S converted all outstanding...

Read more

CelLBxHealth PLC Presents Proof-of-Concept Study

November 5, 2025 2:00 AM

CELLBXHEALTH plc (AIM:CLBX)(OTCQX:ANPCY), a global leader in circulating tumour cell (CTC) intelligence, announces the presentation of a proof-of-concept study using a Roche Tissue Diagnostics workflow at the 16th World ADC conference, San Diego, USA (Nov 3-6). The World ADC Conference is the largest global event dedicated to antibody-drug conjugates (ADCs), attracting over 1,400 attendees focused on advancing targeted cancer therapies.Roche is...

Read more

Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities

November 5, 2025 2:00 AM

Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ: EVO) today announced its business update for 9M 2025, illustrating the ongoing systematic execution of its strategy. In the D&PD segment, the market for early drug discovery services remained soft, while strategic partnerships are on track and Evotec records strong progress in its partnered asset pipeline. JEB continues its strong...

Read more

Electronic Caregiver Brings Addison Virtual Care Platform to the Annual Session & Primary Care Summit 2025 in Addison, Texas

November 4, 2025 4:45 PM

Electronic Caregiver, Inc. (ECG), a leader in intelligent virtual care solutions, announced today its participation in the Annual Session & Primary Care Summit 2025, hosted by the Texas Academy of Family Physicians (TAFP) and taking place November 13-15 at the Renaissance Dallas Addison Hotel in Addison, Texas.ECG will exhibit in a 10-foot booth, presenting the latest evolution of its Addison Virtual Care Platform - a next-generation solution...

Read more

President Trumps Two Wars: Drug Cartels Abroad, Marijuana Science at Home - We Must Win Both

November 4, 2025 4:25 PM

When new DEA Administrator Terrance "Terry" Cole took office this summer, he inherited two very different wars. One is the war on cartels bloody, international, and long overdue.The other is the quiet, bureaucratic war against medical cannabis research-a conflict that has dragged on for seven years and cost American patients time, hope, and progress. The Enforcement FrontUnder Cole's leadership, the DEA has launched aggressive raids...

Read more

Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth

November 4, 2025 4:17 PM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the third quarter ended September 30, 2025."Delivering 16% growth and achieving record year-over-year revenue for the 19th straight quarter demonstrates the consistency and resilience of our business. Crossing $8 million...

Read more

Strive Pharmacy Expands Footprint with Acquisition of Alachua Facility and New Tampa Location, Cementing Leadership in Patient-Focused Compounding Innovation

November 4, 2025 1:05 PM

Strive Pharmacy, a leader in personalized healthcare solutions, today announced a significant milestone in its ongoing expansion and mission to redefine what's possible in pharmaceutical compounding with the acquisition of a state-of-the-art manufacturing facility in Alachua, FL., and the expansion of Strive's Tampa operations. These moves reflect the company's continued dedication to growth, innovation, and its core philosophy to NEVER...

Read more

AcutePet Urgent Care Expands to South Jersey With Voorhees Opening November 7

November 4, 2025 12:00 PM

AcutePet Urgent Care is proud to announce the opening of its newest location in Voorhees, New Jersey, on Friday, November 7, 2025. Conveniently located at 1006 Kresson Road near The Mansion on Main Street and the Centennial Boulevard intersection, the clinic expands AcutePet's mission to make veterinary care more accessible, providing same-day appointments and high-quality treatment for pets when their needs can't wait.The Ribbon Cutting...

Read more

Sleep Lean Reviews (URGENT REPORT) Doctors Reveal the Truth About This Nighttime Fat Burn Formula In 2025

November 4, 2025 11:35 AM

Across 2025's wellness landscape, few supplements have generated as much curiosity as Sleep Lean. Promising measurable weight-loss results during rest hours, it claims to activate the body's natural "circadian fat-burn" process, a concept backed by emerging chronobiology research. Doctors and users alike are now re-evaluating the long-ignored connection between sleep quality, cortisol balance, and nighttime metabolism.Our editorial team...

Read more

The Brain Song Reviews (URGENT REPORT) Doctors Break Silence on the Gamma Wave Audio Revolution in 2025

November 4, 2025 11:10 AM

Across 2025, The Brain Song reviews have ignited a new discussion inside the neuroscience community: can sound frequencies alone sharpen memory, boost focus, and help the aging brain stay alert? For decades, supplements and nootropics dominated this field, but the arrival of a Gamma-wave entrainment program, backed by neuroscientific theory and developed by Dr. James Rivers has challenged that paradigm.Clinical observers note a surge of interest...

Read more

DistillerSR and Elsevier to Collaborate on the Integration of Elsevier's Embase(R) and DistillerSR's Evidence Management Platform

November 4, 2025 11:00 AM

DistillerSR, the market leader in AI-enabled literature review automation and evidence management, today announced an agreement with Elsevier that will provide direct integration between DistillerSR and Elsevier's premier biomedical database, Embase. This collaboration will accelerate literature evidence synthesis, improve data quality, and provide faster insights for clinical research and regulatory submissions. The agreement ensures customers...

Read more

Exousia Pro Announces Breakthrough In Exosome-Based Delivery

November 4, 2025 10:40 AM

Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced a significant technical milestone: the successful loading of milk-derived exosomes with Cannabidiol (CBD) material. These specialized exosomes are engineered to remain intact as they traverse the digestive tract, a pivotal advancement in oral drug delivery.Our scientific team, collaborating closely with Dr....

Read more

Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend

November 4, 2025 10:00 AM

Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Kevin C. Timken, Esq to its Board of Directors. Mr. Timken, who served as UTMD's outside legal counsel for over twenty years prior to his retirement in 2025, graduated with a J.D. degree from the University of Utah College of Law in 1997. The Board believes his robust understanding of the functional and strategic challenges that the Company faces will...

Read more

ForCast Orthopedics Receives Qualified Infection Disease Product (QIDP) Designation From FDA for Second Pipeline Program

November 4, 2025 10:00 AM

ForCast Orthopedics, a development-stage company focused on modernizing care for complex orthopedic infections, today announced that the US Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) Designation for the Company's second pipeline program, FC002, for the treatment of periprosthetic joint infection (PJI).FC002 combines ForCast's proprietary Wearable Intra-Articular Infusion System (WIIS) delivery...

Read more

Williamsburg-Based Faith Recovery Earns CARF Accreditation

November 4, 2025 9:30 AM

Faith Recovery, a Williamsburg-based drug recovery program, recently earned a three-year accreditation from the Commission on Accreditation of Rehabilitation Facilities.Faith Recovery, which has been operating since 1979, notes it has provided hope to individuals and families facing the devastation of addiction and has continually evolved to better serve the men and women in its care. That same hope now shines through a new milestone, it adds,...

Read more

CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference

November 4, 2025 9:00 AM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential best-in-class, anti-CD38 monoclonal antibody for patients with organ transplant rejection and autoimmune diseases, today announced that the CASI management team will participate at the Guggenheim Healthcare Innovation Conference 2025 in a fireside chat at 9:30 AM ET on November 12 in Boston, MA. CASI will also host...

Read more